Suven Life Sciences Limited

Suven Life Sciences Limitedverified

SUVEN.NS

Price:

$168.06

Market Cap:

$37.04B

Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities (NCEs) in central nervous system therapies. Its product candidates include SUVN-502 for the treatment of Alzheimer's disease and neuropsychiatric symptoms; SUVN-G3031, a potent and selective histamine H3 receptor inverse agonist for the treatment of sleep and cognitive disorders; and SUVN-911, a novel, potent, and selective a4ß2 nicotinic acetylcholine r...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2003-10-24

Stock Exchange

NSE

Ticker

SUVEN.NS

The Enterprise Value as of December 2025 (TTM) for Suven Life Sciences Limited (SUVEN.NS) is 37.04B

According to Suven Life Sciences Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 37.04B. This represents a change of 7.50% compared to the average of 34.46B of the last 4 quarters.

Suven Life Sciences Limited (SUVEN.NS) Historical Enterprise Value (quarterly & annually)

How has SUVEN.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Suven Life Sciences Limited over the last ten years is 8.93B. The current 37.04B Enterprise Value has changed 41.37% with respect to the historical average. Over the past ten years (40 quarters), SUVEN.NS's Enterprise Value was at its highest in in the June 2025 quarter at 53.73B. The Enterprise Value was at its lowest in in the June 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

8.93B

Median

5.16B

Minimum

105.80M

Maximum

26.29B

Suven Life Sciences Limited (SUVEN.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Suven Life Sciences Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.84%

Maximum Annual Enterprise Value = 26.29B

Minimum Annual Increase = -82.01%

Minimum Annual Enterprise Value = 105.80M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202526.29B15.58%
202422.75B211.71%
20237.30B-45.77%
202213.46B31.60%
202110.23B238.06%
20203.02B18.82%
20192.55B62.21%
20181.57B-23.64%
20172.06B1.84%
2016105.80M-82.01%

Suven Life Sciences Limited (SUVEN.NS) Average Enterprise Value

How has SUVEN.NS Enterprise Value performed in the past?

The current Enterprise Value of Suven Life Sciences Limited (SUVEN.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

18.78B

5-year avg

16.00B

10-year avg

8.93B

Suven Life Sciences Limited (SUVEN.NS) Enterprise Value vs. Peers

How is SUVEN.NS’s Enterprise Value compared to its peers?

Suven Life Sciences Limited’s Enterprise Value is less than Sun Pharma Advanced Research Company Limited (52.12B), less than Sun Pharma Advanced Research Company Limited (52.12B), less than Aarti Drugs Limited (41.94B), less than Aarti Drugs Limited (41.94B), greater than RPG Life Sciences Limited (35.35B), greater than RPG Life Sciences Limited (35.35B), less than Innova Captab Limited (42.38B), less than Orchid Pharma Limited (45.62B), greater than Gufic Biosciences Limited (34.81B), greater than Gufic Biosciences Limited (34.81B),

Build a custom stock screener for Suven Life Sciences Limited (SUVEN.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Suven Life Sciences Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Suven Life Sciences Limited (SUVEN.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Suven Life Sciences Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Suven Life Sciences Limited's Enterprise Value?

What is the highest Enterprise Value for Suven Life Sciences Limited (SUVEN.NS)?

What is the 3-year average Enterprise Value for Suven Life Sciences Limited (SUVEN.NS)?

What is the 5-year average Enterprise Value for Suven Life Sciences Limited (SUVEN.NS)?

How does the current Enterprise Value for Suven Life Sciences Limited (SUVEN.NS) compare to its historical average?